# Effects the Glycemic Index on Metabolic Risk Markers

> **NCT00695825** · NA · COMPLETED · sponsor: **Maastricht University Medical Center** · enrollment: 30 (estimated)

## Conditions studied

- Metabolic Syndrome X

## Interventions

- **DIETARY_SUPPLEMENT:** Low GI+high GI
- **DIETARY_SUPPLEMENT:** High GI+low GI

## Key facts

- **NCT ID:** NCT00695825
- **Lead sponsor:** Maastricht University Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-04-01
- **Primary completion:** 2006-11-30
- **Final completion:** 2008-12-31
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2018-04-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00695825

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00695825, "Effects the Glycemic Index on Metabolic Risk Markers". Retrieved via AI Analytics 2026-08-01 from https://api.ai-analytics.org/clinical/NCT00695825. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*